These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3307177)

  • 21. Natural killer-22 cells in the synovial fluid of patients with rheumatoid arthritis are an innate source of interleukin 22 and tumor necrosis factor-α.
    Ren J; Feng Z; Lv Z; Chen X; Li J
    J Rheumatol; 2011 Oct; 38(10):2112-8. PubMed ID: 21765110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of antibody-dependent cell-mediated cytotoxicity in rheumatoid synovial fluid.
    Abrahamsen TG
    Scand J Rheumatol; 1981; 10(1):55-61. PubMed ID: 7221496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral immunity of synovial fluid.
    Hrncír Z; Salavec M; Tichý M; Vavrina J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1977; 20(1):1-103. PubMed ID: 304599
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies into the occurrence of soluble antigen-antibody complexes in disease. VII. Clinical-laboratory correlations of immunoglobulin complexes in rheumatoid synovial fluid.
    Russell ML; Gordon DA; BRoder I
    J Rheumatol; 1974 Jun; 1(2):153-8. PubMed ID: 4477197
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunopathological study of synovial tissue and fluid in rheumatoid arthritis].
    Xu WD; Shih GY; Cai XH
    Zhonghua Nei Ke Za Zhi; 1985 May; 24(5):284-6, 319. PubMed ID: 3902400
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunologic models used for the study of rheumatoid arthritis.
    Jasin HE; Cooke TD; Hurd ER; Smiley JD; Ziff M
    Fed Proc; 1973 Feb; 32(2):147-52. PubMed ID: 4688655
    [No Abstract]   [Full Text] [Related]  

  • 27. Study of cellular immunity in rheumatoid arthritis: inhibition of leucocyte migration by a synovial extract.
    Kahan A; Alcalay M; Amor B; Delbarre F
    Biomedicine; 1975 Apr; 23(3):111-5. PubMed ID: 1222225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody-dependent direct cytotoxicity of human lymphocytes. II. Studies on peripheral blood lymphocytes, synovial fluid cells and sera from patients with rheumatoid arthritis.
    Scheinberg MA; Cathcart ES
    Clin Exp Immunol; 1976 May; 24(2):323-7. PubMed ID: 1084244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of rheumatoid synovial fluid lymphocytes. I. Evidence for activated natural killer- (NK) like cells.
    Silver RM; Redelman D; Zvaifler NJ; Naides S
    J Immunol; 1982 Apr; 128(4):1758-63. PubMed ID: 6460811
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of articular fluid on leukocyte migration inhibition in patients with rheumatoid arthritis].
    Janicka U; Mackiewicz S
    Reumatologia; 1975; 13(2):99-103. PubMed ID: 1135539
    [No Abstract]   [Full Text] [Related]  

  • 31. [Determination of the migration inhibition factor in the blood serum and synovial fluid in rheumatic diseases].
    Konenkov VI; Bogel'man DG; Shirinskiĭ VS; Mishin VM; Lozovoĭ VP
    Ter Arkh; 1982; 54(6):34-6. PubMed ID: 7051395
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
    Naama JK; Mitchell WS; Whaley K
    Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
    Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
    Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current state of the problem of immunopathology of rheumatoid arthritis].
    Zborovskiĭ AB; Lempert BA
    Sov Med; 1980; (6):64-9. PubMed ID: 6447923
    [No Abstract]   [Full Text] [Related]  

  • 35. Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype.
    Pridgeon C; Lennon GP; Pazmany L; Thompson RN; Christmas SE; Moots RJ
    Rheumatology (Oxford); 2003 Jul; 42(7):870-8. PubMed ID: 12730548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of rheumatoid arthritis.
    Ziff M
    Fed Proc; 1973 Feb; 32(2):131-3. PubMed ID: 4569690
    [No Abstract]   [Full Text] [Related]  

  • 37. Occurrence of -globulin complexes in serum and joint fluid of rheumatoid arthritis patients: use of monoclonal rheumatoid factors as reagents for their demonstration.
    Winchester RJ; Kunkel HG; Agnello V
    J Exp Med; 1971 Sep; 134(3 Pt 2):286s-295s. PubMed ID: 4998932
    [No Abstract]   [Full Text] [Related]  

  • 38. [T- and B-lymphocytes and the rheumatoid factor in the synovial fluid and peripheral blood in rheumatoid arthritis].
    Redaĭtene EI; Taletene IP
    Vopr Revm; 1980; (4):40-3. PubMed ID: 6972669
    [No Abstract]   [Full Text] [Related]  

  • 39. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.
    Luthra HS; McDuffie FC; Hunder GG; Samayoa EA
    J Clin Invest; 1975 Aug; 56(2):458-66. PubMed ID: 125289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of mycoplasmal antigens in immune complexes from rheumatoid arthritis synovial fluids.
    Clark HW; Coker-Vann MR; Bailey JS; Brown TM
    Ann Allergy; 1988 May; 60(5):394-8. PubMed ID: 3369750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.